1. Home
  2. TOI vs TECX Comparison

TOI vs TECX Comparison

Compare TOI & TECX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo The Oncology Institute Inc.

TOI

The Oncology Institute Inc.

N/A

Current Price

$2.76

Market Cap

327.6M

Sector

Health Care

ML Signal

N/A

Logo Tectonic Therapeutic Inc.

TECX

Tectonic Therapeutic Inc.

N/A

Current Price

$34.76

Market Cap

393.0M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
TOI
TECX
Founded
2007
2019
Country
United States
United States
Employees
N/A
51
Industry
Medical/Nursing Services
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
327.6M
393.0M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
TOI
TECX
Price
$2.76
$34.76
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
5
Target Price
$6.00
$80.40
AVG Volume (30 Days)
1.3M
551.2K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$28.51
N/A
Revenue Next Year
$27.09
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.63
$13.70
52 Week High
$4.88
$35.99

Technical Indicators

Market Signals
Indicator
TOI
TECX
Relative Strength Index (RSI) 47.41 74.75
Support Level $2.37 $16.83
Resistance Level $2.97 N/A
Average True Range (ATR) 0.20 2.56
MACD 0.03 1.26
Stochastic Oscillator 51.20 93.12

Price Performance

Historical Comparison
TOI
TECX

About TOI The Oncology Institute Inc.

The Oncology Institute Inc offers oncology services committed to improving cancer prevention, diagnosis, treatment, research, and education. The company provides services including infusion centres. In-house dispensary, Outpatient blood transfusion, Outpatient stem cell transplant, financial counseling, clinical trials, comprehensive lab testing, and end-of-life counseling. The business operates in three operating segments dispensary, patients services and clinical trials and others. Key revenue is earned from providing patient services. Majority of revenue is from patients services.

About TECX Tectonic Therapeutic Inc.

Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. Company focus on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.

Share on Social Networks: